Ca-PRI 2020 - Oxford
Tailoring our approach to cancer control in primary care
Wednesday, 01 April 2020 to Friday, 03 April 2020
St Hugh's College, University of Oxford. OX2 6LE
Registration is open- the early bird rate has been extended until 28th February
Welcome to the Ca-PRI 2020 Conference
The early bird rate is now available until Friday 28th February so book now before the price increases.
Our keynote speakers are now confirmed:
Professor Peter Johnson - National Clinical Director for Cancer, NHS England and NHS Improvement:
Primary care's role in cancer prevention: diagnosis and management in the NHS Long Term Plan
Dr Ruth Etzioni - Fred Hutchinson Cancer Research Center
Evaluating the risks of cancer overdiagnosis in symptomatic patients in primary care
Dr Barry Kramer - Recent Director of the NCI Division of Cancer Prevention
Overdiagnosis: incidentalomas on Symptomatic People (A Biological Challenge and Clinical Dilemma in a Data-penic World)
Professor Sir John Bell - Future Health Session: Cancer Control and the UK's life sciences strategy
History of Science Museum
Network with your peers at the wonderful setting of the History of Science Museum in Broad Street whilst enjoying welcome drinks. This fascinating building is the site of the original Ashmolean Museum, the oldest purpose-built museum in the world, and now houses a collection specifically focused on the history of science.
Half-hour tours will be running as part of the reception.
More information about the museum and its collections can be found here:https://www.hsm.ox.ac.uk/
What is Ca-PRI?
The Cancer and Primary Care Research International Network (Ca-PRI) is an open, multidisciplinary network for researchers in primary cancer care and related areas. Ca-PRI was founded in 2008 and welcomes researchers from all disciplines related to research and development in the fields of cancer care in primary care. Ca-PRI promotes greater international collaboration in primary care and cancer research primarily by supporting networking and arranging a yearly conference. Focus is on the role of primary care throughout the cancer journey from prevention to palliative care. Thus, research aspects are:
Prevention and awareness
It is estimated that up to a third of cancers are preventable, and hence that cancer control efforts must include lifestyle advice to encourage individuals to modify potentially damaging behaviours.
Primary care is well placed to contribute to these efforts, including in the provision of smoking cessation services and advice on physical exercise and diet, although there is a need for further work on the most effective interventions for each of these factors.
Similarly there is recognition of the need to examine the range of understanding of and response to the signs and symptoms of potential cancer in order to promote earlier diagnosis, and in particular to compare these in different health care contexts.
Early detection and diagnostic pathway
It is recognised that primary care has a crucial role to play in awareness raising of cancer symptoms, responding to symptoms as they present in primary care and undertaking appropriate and timely investigations and referrals.
Symptoms of cancer are very common in primary care, and there is an emerging body of evidence underpinning more effective and comprehensive cancer risk assessment.
This includes the use of new diagnostic algorithms based on symptoms and risk factors. Further, there is much to be gained from comparisons of the cancer diagnostic process in different contexts and countries.
Primary care plays an important role in the delivery of cancer screening to patients, whether in support of organised screening programmes at a national or regional level, or opportunistic approaches to individuals accessing health care services.
Systematic reviews examining the evidence for strategies to increase participation in screening have identified a number of effective primary care based approaches (such as endorsement by a family practitioner, or telephone counselling).
However, strategies to improve uptake typically produce only incremental increases and there is a need to further develop an evidence base for effective interventions for diverse populations, ideally informed by comparative studies in across different health care settings.
Follow-up and survivorship
Although cancer care has traditionally been provided in secondary care, the role of primary care in follow-up following initial treatment is the focus of a great deal of interest in many countries, including the development and comparison of models of follow-up for those patients where monitoring for recurrence and addressing psychosocial issues can be effectively and safely delivered the primary care.
Similarly, as the number of patients living with and beyond cancer is increasing globally due to changes in population demographics and improved cancer rates, the health care needs of this patient group are increasingly recognised as is the role of primary care cancer in contributing to the provision of patient-centred information on dealing with physical, psychosocial as well as financial and family concerns.
Primary care provides palliative and end of life care to the majority of cancer (and non-cancer) patients throughout the world; there have been a number of important initiatives in several countries in recent years to strengthen the evidence base for this aspect of care.
However, there is a continued need for better clarification and standardisation of definitions of end of life care. Models of good practice need to be developed and evaluated.
Primary care providers have a vital role in communicating cancer risk to patients with or without symptoms. A variety of mechanisms exist to underpin risk communication in primary care and further evidence is required to identify the most effective strategies.
Further, sharing of clinical information between various healthcare providers is a vital element of effective cancer control.
There is evidence from many countries around the world of delays in cancer diagnosis arising from poor communication and again more research and evidence is needed to address these issues.
Conceptual and methodological issues in research in the field
There is a growing recognition that international high quality research in early diagnosis of cancer is hindered by a lack of consensus on definitions and methods used in early diagnosis research. For example there is no widespread agreement on defining “time to diagnosis” or how to measure it.
There are challenging measurement and methodological issues in this kind of research – such as recall bias, dealing with long-term symptoms and asymptomatic presentation. Existing literature uses a variety of definitions and methodological approaches to early diagnosis research making international comparisons difficult.
To address this need for consistency in terminology and methods a number of Consensus Working Groups have been proposed in areas including early diagnosis and survivorship, achieving consensus and consistency in methodological approaches which will underpin future international collaborative research efforts.
Ca-PRI is led by the Executive group whose most prominent task is to ensure that the international network exists and is active. However, no network exits without each member being active and we hope that you may want to contribute and obtain the advantages of being member.
Authors are allocated 15 minutes, ten plus five for questions. Please keep to the time limit to ensure all presenters receive equal opportunity.
Room allocation, running order and Chairperson can be found in the conference programme available soon. Please note the running order is subject to change in case of any absences or if papers are better suited in a different order.
Using your own laptop is not a problem but can delay proceedings. We will request that you present last to avoid eating into the session time. Note, this could cut your own presentation time short.
Presentations will not be requested prior to the conference, please bring a copy with you on a USB stick for transferring onto the laptop already set up in the room.
Rooms will be open 30 minutes before each session for you to load (and run through) slides.
Clearly labelled presentations should be placed into a pre-named folder e.g. Thursday April 2nd am/pm on the desk top, a team member will be available to offer assistance if needed. Please be in the room and prepared at least five minutes before the session is due to start.
Each poster should be on view up to and including the last break on the last day of the event. A guided poster session will take place on the afternoon of April 2nd, please make yourself available for a brief discussion of your research with other members of the delegation and scientific committee.
The mounting board for each poster is 6′ high x 3′ wide (portrait) and can accommodate one A0 poster each side.
Poster boards will be numbered. Your poster number will be the number beside your title in the printed programme available soon. Velcro fastenings will be provided.
Workshop 90 minutes
Workshops are led by one or more facilitators and should include objectives and learning outcomes. Participants should work, think and process. lots of interaction, not just a talking shop.